A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors.
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
7
9
2020
pubmed:
8
9
2020
medline:
5
5
2021
Statut:
ppublish
Résumé
Few models of transition have been proposed for inflammatory bowel disease (IBD). The aim of the present study is to evaluate the feasibility of a transition model and the predictive factors for success/failure. Patients with low activity or remission IBD were enrolled. Proposed model: three meetings every four-six weeks: the first one in the pediatric center (Bambino Gesù Children's Hospital); the second one, in the adult center (Foundation Polyclinic University A. Gemelli), with pediatric gastroenterologists; the last one, in the adult center, with adult gastroenterologists only. Questionnaires included anxiety and depression clinical scale, self-efficacy, quality of life, visual-analogic scale (VAS). Transition was considered successful if the three steps were completed. Twenty patients were enrolled (range 18-25 years; M/F: 12/8; Ulcerative Colitis/Crohn's Disease 10/10); eight accepted the transition program, four delayed the process and eight refused. Patients who completed transition generated higher scores on the resilience scale, better scores on well-being perception, and had lower anxiety scores. Patients who failed transition were mostly women. The perceived utility of the transition program was scored 7.3 on a VAS scale. The proposed transition program seems to be feasible. Psychological scores may help in selecting patients and predicting outcomes.
Identifiants
pubmed: 32894553
doi: 10.26355/eurrev_202008_22644
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM